Erythroid progenitors differentiate in erythroblastic islands, bone marrow niches composed of erythroblasts surrounding a central macrophage. Evidence suggests that within islands adhesive interactions regulate erythropoiesis and apoptosis. We are exploring whether erythroid intercellular adhesion molecule-4 (ICAM-4), an immunoglobulin superfamily member, participates in island formation. Earlier, we identified α V integrins as ICAM-4 counterreceptors.
INTRODUCTION
Erythroid progenitors proliferate, differentiate and enucleate within specialized bone marrow niches, termed erythroblastic islands. [1] [2] [3] [4] These structural units are composed of developing erythroblasts surrounding a central macrophage. It is apparent from ultrastructural studies that extensive cell-cell interactions, both erythroblast-macrophage, as well as erythroblasterythroblast, occur within these three dimensional structures. However, little is known regarding either the molecular nature or functional role of the specific adhesive interactions. We are exploring the potential function of erythroid ICAM-4, a recently characterized member of the immunoglobulin superfamily, in erythroblastic island formation. ICAM-4 expression is limited to erythroid tissue but, to date, there is no information on its role in erythropoiesis. We earlier identified α 4 β 1 and α V -family integrins as ICAM-4 binding partners. 5 Since macrophages express α V and erythroblasts exhibit α 4 β 1 , ICAM-4 is an attractive candidate for mediating erythroblast-erythroblast interactions via ICAM-4/α 4 β 1 binding and regulating adhesion of erythroblasts to central macrophages via ICAM-4/α V binding.
ICAM-4, which carries the Lansteiner Wiener (LW) blood group antigen system, has strong sequence homology with other members of the ICAM protein superfamily. 6, 7 It is composed of two extracellular immunoglobulin-like domains, an N-terminal I set and a membrane proximal I2 set, and a single membrane spanning domain. 8, 9 ICAM-4 is detected early during terminal differentiation, concordant with surface expression of glycophorin A and RhGP. 10 Hence, the timing of ICAM-4 expression during erythropoiesis is consistent with a functional role in erythroblastic islands.
To elucidate the structural basis of α V integrin-ICAM-4 interaction we earlier performed targeted mutagenesis of ICAM-4 surface-exposed amino acid residues, using a molecular model of ICAM-4 derived from the crystal structure of closely related ICAM-2. 11 Employing adhesion assays with cells that bind ICAM-4 via α V β 1 and α V β 5 , we identified a patch or "footprint" that mediates adhesion to α V integrins composed of two series of residues on the N-terminal extracellular domain: F18, W19, V20 and R92, A94, T95, S96, R97. In the protein structure these eight residues are close to one another, suggesting that this region is crucial for ICAM-4 attachment to α V integrins. We also tested synthetic peptides comprised of sequences of ICAM-4
shown to be involved in adhesion to α V integrins and found that they inhibited cell binding, providing independent support for the role of the proposed footprint in α V integrin binding.
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To explore whether ICAM-4 participates in erythroblastic island formation we generated ICAM-4 null homozygous mice and studied whether islands were perturbed. For these investigations we established quantitative and reproducible live cell techniques for harvesting intact islands from mouse bone marrow or reforming islands in vitro from single cell suspensions of mouse marrow. Applying these methods, we observed a striking decrease in the number of islands formed in vivo or in vitro by ICAM-4 null erythroblasts. Collectively, the results of this phenotypic analysis provide convincing evidence for ICAM-4 in erythroblastic island formation.
Further, we determined that synthetic peptides that block ICAM-4/α V adhesion caused a marked concentration dependent decrease in islands reconstituted from single cell suspensions of wild type mouse marrow, thereby identifying erythroblast ICAM-4 binding to macrophage α V integrins as functionally important attachments. We postulate that this newly identified erythroblast integrin counterreceptor may be crucial not only for adhesive integrity of island structure but also for initiating intracellular signaling essential for normal erythroid terminal differentiation.
MATERIALS AND METHODS

Generation of mice lacking ICAM-4.
For targeted gene deletion, we designed a construct to delete 1.2kb of ICAM-4 genomic sequence encoding exons 1-3, which encompasses the entire protein coding region 12 (Fig 1) . To construct the targeting vector we ligated into the pPN2T-hGHterm vector 13,14 a 4.7 kb "long arm" of genomic DNA from the 5' end of the region to be deleted using EcoRI restriction site and a 1.3kb "short arm" from the 3'deletion boundary using 
RESULTS
Generation of knockout mice.
To study the physiological role of ICAM-4 in erythroblastic islands we targeted ICAM-4 for germ line deletion in mice. The mouse erythrocyte ICAM-4 gene of 1.2kb is composed of 3 exons (Fig 1) . 12 Exons 1-3, encompassing the entire protein coding domain, were targeted for replacement with the vector pPN2T-hGHterm, containing a PGKneomycin resistance cassette modified with polyA-signal/terminator from the human growth hormone N-gene (Fig 1) (Fig 2A) . Deletion of ICAM-4
DNA and protein was further confirmed by PCR analysis of tail genomic DNA and Western blotting of erythrocyte membranes. Employing a multiplex PCR genotyping assay using primers for the ICAM-4 and neo genes, ICAM-4 primers generated a 528bp fragment while neo primers produced a 381bp fragment (Fig 2B) . This assay allowed us to readily distinguish between wild type, heterozygous and ICAM-4 null mice, thereby enabling the determination of the genotype of each mouse that was used experimentally. When Western blots of equivalent amounts of erythrocyte membranes from wild type and knockout mice were probed with antibody recognizing mouse ICAM-4, a band of appropriate size for ICAM-4 was present in wild type membranes and lacking in knockout membranes (Fig 2C) . No reactivity was observed using preimmune rabbit control serum (data not shown). As a positive control, human erythrocyte membranes were probed with BS56, a well-characterized antibody against an epitope on the LW blood group active extracellular region of ICAM-4 15 ( Fig 2C) . The immunoreactive band observed in human membranes migrated at a similar molecular weight as the band observed in wild type mouse erythrocyte membranes. Together, these data confirm the targeted deletion of the ICAM-4 gene.
Reconstituted erythroblastic islands.
To begin to test whether ICAM-4 has a functional role in erythroblastic islands we developed a quantitative live cell assay for reforming islands from single cell suspensions of freshly harvested mouse bone marrow. Adult mice 3-5 months of age were used and all females were virgins. A single cell suspension was prepared, then cells were incubated for carefully controlled times in media containing Manganese. We determined that we could identify islands and their cellular components by three color immunofluorescent microscopy employing fluoresceinated erythroid-specific Ter119 antibody 17 , macrophage-specific F4/80 antibody 18, 19 and a DNA probe (Fig 3A-C) . We observed that the number of cells per island varied as did their stage of differentiation, consistent with observations by others of erythroblastic islands formed in vivo. [20] [21] [22] [23] [24] Since surface expression of Glycophorin A increases during terminal differentiation, the intensity of Ter119 staining served as an effective indicator of erythroblast stage. A faint blush of
Ter119 fluorescence was present in early erythroblasts and increasing degrees of staining were observed in progressively more differentiated cells. We also found that the fluorescence intensity of Ter119 label varied among erythroblasts in an individual island, indicating that islands were composed of erythroblasts at various stages of differentiation. Young, multilobulated reticulocytes were present in many islands, again consistent with prior descriptions of erythroblastic islands formed in vivo. To determine the amount of variation in total number of islands that reformed from a single cell suspension of 1 x 10 5 cells, we counted islands containing 6 or more erythroblasts in experiments on 10 different mice. Total islands were counted at the beginning (i.e. end of the incubation period) and conclusion of each experiment.
We found that the number of reconstituted islands in control mice was highly reproducible (918 +/-148) and did not vary substantially from experiment to experiment using different mice ( Fig   3D) .
Erythroblastic island formation is decreased in ICAM-4 null mice.
To test for functional ICAM-4 mediated adhesion in erythroblastic islands, we analyzed (Fig 4A) .
Erythroblastic islands formed in vivo.
In addition to analyzing erythroblastic islands reconstituted in vitro, we wanted to develop the capability to study islands that had been formed in vivo. Hence, we performed experiments to establish methodology for reproducibly harvesting intact erythroblastic islands from mouse bone marrow. We determined that by gently extracting marrow and removing bone and tissue fragments we were able to retain erythroblastic island structures. As with the reconstituted islands, we identified islands formed in vivo and their cellular components by three color immunofluorescent microscopy employing fluoresceinated erythroid-specific Ter119 antibody, macrophage-specific F4/80 antibody and a DNA probe. We found that the number of harvested islands in normal mice was very reproducible and equaled 898 +/-246 in volume equivalent to 1 x 10 5 bone marrow cells (Fig 4B) .
Erythroblastic islands formed in vivo are decreased in ICAM-4 null mice.
To determine the ability of ICAM-4 null erythroblasts to form islands in vivo we collected and quantitated intact islands from freshly harvested mouse bone marrow. Similar to the in vitro data, we found a marked decrease in the percentage of islands from bone marrow of ICAM-4 null mice compared to wild type littermates. We observed a 64% decrease in the total number of islands from ICAM-4 null mice compared to wild type littermates. Control wild type cells reformed 898 +/-246 islands, while ICAM-4 null cells reformed 327 +/-97 islands (Fig 4B) .
Taken together, the results of this phenotypic analysis provide convincing evidence that ICAM-4 is critical in erythroblastic island formation.
Erythroblastic island formation is inhibited by peptides that block adhesion of ICAM-4 to α V integrins.
We next tested the effects on erythroblastic island formation of two synthetic peptides that we have previously shown block ICAM-4/α V adhesion. 11 Peptides V(16)PFWVRMS (FWV) and T(91)RWATSRI (ATSR), correspond to sequences within the α V binding region located on the A and G strands of ICAM-4 domain 1, respectively (Fig 5A) . A single cell suspension was prepared from freshly harvested normal mouse marrow and then cells were incubated for carefully controlled times in media containing Manganese and then in media containing various peptides or media alone. Both peptides caused a marked, concentration dependent decrease in the percentage of islands formed. 0-1.0mM, 1.0-2.0mM, and 2.0-3.0mM ATSR inhibited island formation 17%, 28%, and 53% respectively (Fig 5B) . While 0-1.0mM, 1.0-2.0mM, and 2.0-3.0mM FWV inhibited island formation 20%, 37%, and 57% respectively (Fig 5C) . These data strongly suggest that erythroblast ICAM-4 binding to macrophage α V integrins is critical for erythroblastic island formation.
Central macrophages isolated from erythroblastic islands express the α V integrin subunit.
Macrophages vary phenotypically and although macrophages from various tissues have been shown to express the α V integrin subunit CD51, it was crucial to confirm its presence on the surface of erythroblastic island central macrophages. Therefore, we performed α V integrin phenotyping on central macrophages isolated from erythroblastic islands. For these investigations, intact islands were separated from single cells by velocity sedimentation, the islands were disrupted and then erythroblasts removed from the single cell suspension using
Ter119 microbeads. The remaining cells were analyzed by immunofluorescent microscopy using macrophage-specific probe F4/80 and anti-CD51. In double label experiments we observed colocalization of the two markers (Fig 6) , clearly showing that central macrophages isolated from erythroblastic islands express the α V integrin subunit.
DISCUSSION
Terminally differentiating erythroblasts express a variety of cell adhesion molecules on their surfaces. 10, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] These proteins mediate interactions between erythroblasts and stromal cells and between erythroblasts and extracellular matrix components, such as fibronectin and laminin.
Prior to the current investigations the function of erythroblast adhesion molecule ICAM-4 during differentiation was unknown.
As a definitive exploration of whether ICAM-4 mediated adhesive interactions function in erythroblastic island integrity, we generated ICAM-4 null mice and quantitated these marrow substructures. In novel island reconstitution experiments we observed a 47% decrease in the total number of islands formed from bone marrow cells from ICAM-4 null mice compared to wild type littermates. We felt that it was crucial to also obtain data on in vivo island formation in these null mice. To achieve this objective we developed techniques for harvesting and analyzing intact erythroblastic islands that were both reproducible and quantitative. Applying these novel methods, we found a 64% decrease in islands harvested from ICAM-4 null mice compared to wild type littermates. This striking decrease in islands formed both in vivo and in vitro by ICAM-4 null erythroblasts clearly shows that ICAM-4 protein, that is only expressed in erythroid tissue, is critical in erythroblastic island formation.
A major finding of the current study is that adhesive interactions between erythroblast ICAM-4 and its α V integrin counterreceptor on central macrophages is critical for erythroblastic island
integrity. An important aspect of the present study is our unequivocal demonstration by live cell microscopy that central macrophages of native bone marrow erythroblastic islands indeed express α V integrin. We consider this finding critical for making a definitive conclusion regarding a role for macrophage α V integrin in erythroblastic island formation, in view of the marked heterogeneity of macrophage phenotypes. Using the quantitative and reproducible live cell technique that we developed for reforming islands in vitro, we observed that synthetic peptides ATSR and FWV, that block ICAM-4/α V adhesion 11 , caused a marked concentration dependent decrease in the percentage of islands reconstituted from bone marrow single cell suspensions. ATSR and FWV inhibited island formation 53% and 57%, respectively, at the highest peptide concentrations tested. Significant similarity in the inhibiting effects of the two peptides was also observed at lower peptide concentrations. Our findings that two different peptides, each comprised of amino acid residues within the α V integrin binding region on ICAM-4, blocked island reconstitution to similar degrees, strongly argues for the importance of ICAM-4/α V attachments in three dimensional erythroblastic islands.
Earlier we reported marked similarities between mouse and human ICAM-4 protein with 68% overall identity. 12 Critical cysteine residues and other key residues within the two extracellular IgSF domains are conserved, suggesting that these disulfide-bonded domains are similarly folded in human and murine proteins and may have analogous functional properties. In support of this we have determined that the α V integrin-binding properties of ICAM-4 are conserved across species. 12 These data strongly suggest that our current findings regarding the adhesive role of ICAM-4 in mouse erythroblastic island integrity may be equally pertinent to human erythropoiesis.
Growing evidence supports the concept of erythroblastic islands as microenvironmental niches within bone marrow where cell-cell attachments, in concert with cytokines, are crucial for terminal erythroid differentiation and regulation of apoptosis. To date, only a few receptorcounterreceptor interactions have been described, but the data regarding their impact on erythropoiesis is tantalizing. Previous studies identified a transmembrane protein Emp (erythroblast macrophage protein) present in both erythroblasts and macrophages, that appears to mediate erythroblast-erythroblast and erythroblast-macrophage attachments via homophilic binding. 3, 35 Another identified attachment within erythroblastic islands occurs between erythroblast α 4 β 1 integrin and its counterreceptor, VCAM-1, in central macrophages. 36 Island integrity is perturbed by antibodies to either VCAM-1 or α 4 β 1 . Finally, a recent report appears to demonstrate the importance of intercellular signaling between erythroblasts in regulating GATA-1 activity. 37 We postulate that the various linkages within erythroblastic islands are dynamic during erythroid development and that the signaling pathways stimulated by these attachments could influence differentiation and enucleation.
Interestingly, Fas/Fas ligand-related regulation of apoptosis also appears to occur within erythroblastic islands. 38 Orthochromatic erythroblasts expressing Fas ligand demonstrate a Fasbased cytotoxicity against immature erythroblasts expressing Fas, that is abolished by high levels of erythropoietin. Fas-independent regulation of apoptosis may also occur within islands. Bone marrow macrophages secret soluble RCAS1 (receptor binding cancer antigen expressed in SiSo cells) that permeabilizes mitochondrial membranes and activates caspases 8 and 3 in immature erythroblasts that express RASC1 receptor. 39 In sum, these findings delineate potential mechanisms for negative regulatory feedback between mature and immature erythroblasts.
In earlier investigations we discovered a novel secreted isoform of mouse ICAM-4, termed ICAM-4S. 12 We found that ICAM-4S mRNA is upregulated late in terminal differentiation, suggesting a regulatory role in late erythropoiesis. Secreted ICAM-4S may compete with cellular ICAM-4 for integrin counterreceptors, thereby interfering with adhesion between membrane ICAM-4 and its binding partners. This potential repressive function of ICAM-4S could enable young reticulocytes to detach from erythroblastic islands in preparation for their egress into the peripheral circulation.
We postulate that the novel receptor-counterreceptor interaction between erythroblast ICAM-4 and macrophage α V integrin identified in the current report may be important not only for adhesive integrity of erythroblastic island structures but also for initiating intracellular signaling essential for normal erythroid terminal differentiation. In addition, the novel quantitative island reconstitution assays we developed are likely to be extremely valuable in furthering our understanding of the molecular basis for cell-cell interactions in erythroblastic islands and in delineating the functional sequeli of these interactions. Histogram of number of erythroblastic islands obtained from wild type (n=6) and ICAM-4 null (n=6). p=0.0001 when compared to islands formed from wild type marrow. 
